Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.4000
+0.0203 (5.35%)
Nov 7, 2025, 11:43 AM EST - Market open
Vaxart Market Cap
Vaxart has a market cap or net worth of $91.38 million as of November 7, 2025. Its market cap has decreased by -49.10% in one year.
Market Cap
91.38M
Enterprise Value
79.49M
1-Year Change
-49.10%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from $60.35M to $91.38M, an increase of 51.42%. That is a compound annual growth rate of 5.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 86.74M | -42.41% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | 625.07M | 3,636.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |